Search Results

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its scientific collaborators, Drs. Vern Lewis and Argel Aguilar-Valles from Carleton University’s Department of Neuroscience (Ottawa, Canada), will present data from a study investigating the mechanisms of BETR-001 (2-bromo-LSD) at the upcoming FENS conference on June 25-29 in Vienna, Austria.

MOBILion Systems, Inc., a life science tools and instrumentation company, has partnered with The University of Natural Resources and Life Sciences, Vienna, an Agilent Partner Lab, to install its first MOBIE® instrument in Europe.

Median Technologies announces that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology, being held in Vienna, Austria, February 28 – March 3, 2024.

Nova Eye Medical Limited is pleased to announce that the Company’s proprietary canaloplasty technology platform will be featured in numerous presentations and posters during the official scientific program of the European Society of Cataract and Refractive Surgeons 41st Congress on September 8-12, 2023 in Vienna, Austria.

AMRA Medical in collaboration with Linköping University, is pleased to announce the completion of baseline enrollment for the innovative ACCESS-ESLD study.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Better Therapeutics, Inc. announced the details of its poster presentation at the European Association for the Study of the Liver Congress 2023, being held from June 21-24 in Vienna, Austria.

QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.